Condensed Consolidated Statements of Stockholders' Equity - USD ($)		Stockholders' Equity, Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Other Comprehensive Income (Loss)
Equity Balance at Jun. 30, 2017		$ 173,083	$ 86	$ 70,101	$ 102,369	$ 527
Net Income		15,291			15,291
Change in unrealized loss on available for sale securities		(2,304)			65	(2,369)
Dividends paid on common stock	[1]	(2,837)			(2,837)
Stock option expense		13		13
Stock grant expense		299		299
Common stock issued value		12,951	4	12,947
Equity Balance at Mar. 31, 2018		196,496	90	83,360	114,888	(1,842)
Equity Balance at Dec. 31, 2017		180,500	86	70,209	110,577	(372)
Net Income		5,258			5,258
Change in unrealized loss on available for sale securities		(1,470)				(1,470)
Dividends paid on common stock	[2]	(947)			(947)
Stock option expense		9		9
Stock grant expense		191		191
Common stock issued value		12,955	4	12,951
Equity Balance at Mar. 31, 2018		196,496	90	83,360	114,888	(1,842)
Equity Balance at Jun. 30, 2018		200,694	90	83,413	119,536	(2,345)
Net Income		21,348			21,348
Change in unrealized loss on available for sale securities		1,773				1,773
Dividends paid on common stock	[3]	(3,551)			(3,551)
Stock option expense		35		35
Stock grant expense		323		323
Common stock issued value		10,757	3	10,754
Equity Balance at Mar. 31, 2019		231,379	93	94,525	137,333	(572)
Equity Balance at Dec. 31, 2018		224,029	93	94,293	131,451	(1,808)
Net Income		7,094			7,094
Change in unrealized loss on available for sale securities		1,236				1,236
Dividends paid on common stock	[4]	(1,212)			(1,212)
Stock option expense		17		17
Stock grant expense		215		215
Common stock issued value		0
Equity Balance at Mar. 31, 2019		$ 231,379	$ 93	$ 94,525	$ 137,333	$ (572)

[1] $.33 per share

[2] $.11 per share

[3] $.39 per share

[4] $.13 per share